Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Clinician, Consumer",Erenumab,Chronic migraine prevention,Erenumab (Aimovig),Options for investment,,Nervous System
